Cargando…
Antigen-specific CD8+ memory stem T cells generated from human peripheral blood effectively eradicate allogeneic targets in mice
BACKGROUND: As the implantation and long-term existence of tumor-specific T cells in host are the prerequisite for adoptive immunotherapy, memory stem T cells (T(SCM)) with self-renewal and differentiation capacity show the greatest potential to implant and long-term exhibit function in vivo, compar...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286512/ https://www.ncbi.nlm.nih.gov/pubmed/30526661 http://dx.doi.org/10.1186/s13287-018-1080-1 |
Sumario: | BACKGROUND: As the implantation and long-term existence of tumor-specific T cells in host are the prerequisite for adoptive immunotherapy, memory stem T cells (T(SCM)) with self-renewal and differentiation capacity show the greatest potential to implant and long-term exhibit function in vivo, compared with other T cells of differentiation stages. Hence, tumor-specific T(SCM) have become potential candidate for adoptive T cell therapy of cancer. Here, we reported a protocol to generate allogeneic antigen-specific CD8+ T(SCM) cells from human PBLs. METHODS: To prepare allogeneic antigen-specific CD8+ T(SCM), we used an LCL named E007 of defined HLA allotyping as simulator, a co-culture of E007 and allogeneic PBLs was carried out in the presence of differentiation inhibitor TWS119 for 7 days. Sorting of proliferation cells ensured the E007-specificity of the prepared T(SCM) cells. The sorted lymphocytes underwent further expansion by cytokines IL-7 and IL-15 for further 7 days, making the E007-specific CD8 + T(SCM) expanded in number. The stem cell and T memory cell properties of the prepared CD8+ T(SCM) were observed in NOD-SCID mice. RESULTS: Our protocol began with 1 × 10(7) PBLs and resulted in 2 × 10(7) E007-specific CD8+ T(SCM) cells in 2 weeks of preparation. The prepared T(SCM) cells exhibited a proliferative history and rapid differentiation into effector cells upon the E007 re-stimulation. Importantly, the prepared T(SCM) cells were able to exist long and reconstitute other T cell subsets in vivo, eradicating the E007 cells effectively after transferred into the LCL burden mice. CONCLUSIONS: This protocol was able to prepare allogeneic antigen-specific CD8+ T(SCM) cells from human PBLs. The prepared T(SCM) showed the properties of stem cells and T memory cells. This study provided a reference method for generation of antigen-specific T(SCM) for T cell adoptive immunotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13287-018-1080-1) contains supplementary material, which is available to authorized users. |
---|